NCT03481881 Pharmacokinetics of Drugs Administered to Children
| NCT ID | NCT03481881 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Pediatric ALL |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2013-08-14 |
| Primary Completion | 2033-08-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2013-08-14 with a primary completion date of 2033-08-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
Eligibility Criteria
Inclusion Criteria: * Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver Exclusion Criteria: * Failure to obtain consent/assent (as indicated)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03481881 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 20 Years, studying Pediatric ALL. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03481881 currently recruiting?
Yes, NCT03481881 is actively recruiting participants. Contact the research team at rachel.greenberg@duke.edu for enrollment information.
Where is the NCT03481881 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT03481881 clinical trial?
NCT03481881 is sponsored by Duke University. The trial plans to enroll 200 participants.